undamentalytics Newsletter

Seastar Medical Holding vs Renovorx

Seastar Medical Holding and Renovorx are similar in size: $1.2m and $1.1m of revenue in their latest fiscal years. Renovorx grew faster (2511.6% against 814.1%). Seastar Medical Holding kept more of each dollar of sales as profit: a net margin of -984.6% against -994.5%.

Latest fiscal yearSeastar Medical HoldingICU, 2025RenovorxRNXT, 2025
Revenue $1.2m $1.1m
Revenue growth 814.1% 2511.6%
Net income −$12.2m −$11.2m
Operating margin -986.6% —
Net margin -984.6% -994.5%
Return on equity — —
Free cash flow — −$11.0m
Cash — $7.0m
Total debt $525,000 $0
Debt to equity 5.0% —
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 17 17
Market value $8.3m $57.8m
Price vs our value range — —
Moat score — —
Insider trades, 12 months 3 buys, 0 sales 13 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.